Loading resource…

Herbert Tilg, MD; Salvatore Petta, MD; Norbert Stefan, MD; Giovanni Targher, MD
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of liver conditions, from simple steatosis to steatohepatitis. It is a significant health concern, affecting a large portion of the adult population globally, particularly those with obesity and type 2 diabetes. The review details diagnostic criteria, associated risks, and treatment options, including lifestyle modifications and surgical interventions. It emphasizes the importance of recognizing MASLD due to its association with serious liver-related complications and other health issues.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

ACUTE PANCREATITIS: MECHANISMS AND THERAPEUTIC APPROACHES
Same clinical topic · Gastroenterology

Functional Dyspepsia
Same clinical topic · Gastroenterology

AGA CLINICAL PRACTICE UPDATE ON EVALUATION AND MANAGEMENT OF REFRACTORY CONSTIPATION: EXPERT REVIEW
Same clinical topic · Gastroenterology

AGA CLINICAL PRACTICE UPDATE ON MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN ADULTS: EXPERT REVIEW
Same clinical topic · Gastroenterology

CURRENT APPROACH TO DIAGNOSIS AND MANAGEMENT OF LOW-PHOSPHOLIPID ASSOCIATED CHOLELITHIASIS SYNDROME
Same clinical topic · Gastroenterology

PRIMER Ulcerative colitis
Same clinical topic · Gastroenterology

PRIMER CROHN’S DISEASE
Same clinical topic · Gastroenterology

UNCOMPLICATED CHOLEDOCHOLITHIASIS IN ELDERLY PATIENTS: A TARGET TRIAL EMULATION COMPARING OBSERVATION AND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
Same clinical topic · Gastroenterology

CELIAC DISEASE
Same clinical topic · Gastroenterology